144 related articles for article (PubMed ID: 937167)
21. [The internal therapy of patients with uric acid containing urinary calculi].
Zöllner N
Urologe; 1968; 7(1):46-50. PubMed ID: 5667553
[No Abstract] [Full Text] [Related]
22. [What is certain in gout therapy?].
Gottesbüren H; Strohmeyer G
Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
[No Abstract] [Full Text] [Related]
23. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic approach to the maintenance of urate homeostasis.
Kelley WN
Nephron; 1975; 14(1):99-115. PubMed ID: 1091870
[TBL] [Abstract][Full Text] [Related]
26. Comparison of allopurinol and probenecid.
Scott JT
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):623-6. PubMed ID: 5335059
[No Abstract] [Full Text] [Related]
27. [Antarthritics. 41].
Mayr E
Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
[No Abstract] [Full Text] [Related]
28. Etiology and treatment of gout--modern concepts.
Riccitelli ML
J Am Geriatr Soc; 1968 Jun; 16(6):719-28. PubMed ID: 5675393
[No Abstract] [Full Text] [Related]
29. The treatment of gout.
Kersley GD
Scott Med J; 1973; 18():Suppl 1:249-50. PubMed ID: 4773968
[No Abstract] [Full Text] [Related]
30. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
Rapado Errazti A
Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):304-6. PubMed ID: 5997999
[No Abstract] [Full Text] [Related]
31. Treatment of the gout and other forms of crystal-induced arthritis.
Rodnan GP
Bull Rheum Dis; 1982; 32(5):43-53. PubMed ID: 6762236
[No Abstract] [Full Text] [Related]
32. Renal effects of uricosuric agents in the Cebus monkey.
Fanelli GM; Bohn DL; Reilly SS
J Pharmacol Exp Ther; 1970 Nov; 175(2):259-66. PubMed ID: 4991506
[No Abstract] [Full Text] [Related]
33. Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):673-80. PubMed ID: 5958697
[No Abstract] [Full Text] [Related]
34. An approach to hyperuricemia and gout.
Palella TD; Kelley WN
Geriatrics; 1984 Nov; 39(11):89-92, 95-6, 101-2. PubMed ID: 6489762
[TBL] [Abstract][Full Text] [Related]
35. [Drug therapy of hyperuricemia].
Gröbner W
Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
[No Abstract] [Full Text] [Related]
36. THE TREATMENT OF GOUT.
TREADWELL B
N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072
[No Abstract] [Full Text] [Related]
37. [Effect of long-term base therapy on the clinical picture of gout].
Baiatova KV
Ter Arkh; 1981; 53(2):87-91. PubMed ID: 7221944
[No Abstract] [Full Text] [Related]
38. Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
Bartels EC
JAMA; 1966 Nov; 198(7):708-12. PubMed ID: 5953324
[No Abstract] [Full Text] [Related]
39. Diagnostic and therapeutic aids in gout and hyperuricemia.
Bollet AJ
Med Times; 1981 Aug; 109(8):23-31. PubMed ID: 7278540
[No Abstract] [Full Text] [Related]
40. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
Erill S; Laporte J
Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
